• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Varian Q3 sales rise 12% in U.S.

Article

Varian reported net earnings of $19.5 million versus $14 million in the same quarter last year. Sales for the quarter totaled $191 million, up 12% from the same period last year. At quarter’s end, backlog for the company was at $538 million, up 17%

Varian reported net earnings of $19.5 million versus $14 million in the same quarter last year. Sales for the quarter totaled $191 million, up 12% from the same period last year. At quarter’s end, backlog for the company was at $538 million, up 17% from the third quarter of last year. Oncology sales were up 15%, and x-ray sales were down 4%.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.